Rep. Julia Letlow Sells Icon Plc (NASDAQ:ICLR) Stock

Key Points

• Rep. Julia Letlow disclosed on March 12 that she sold between $1,001 and $15,000 of Icon Plc (NASDAQ:ICLR) stock on February 12 from her Merrill Lynch investment account.
• Icon shares opened at $100.35 (12‑month range $66.57–$211.00) and the company has a market cap of about $8.1 billion; analysts hold a consensus rating of Hold with a $146.80 target amid mixed ratings.
• Letlow also reported several other small trades in February (each $1,001–$15,000), including sales of HF Sinclair, BXP, AT&T and Broadcom and purchases of Travelers, Regeneron, Vistra and Extra Space Storage.

Representative Julia Letlow (Republican-Louisiana) recently sold shares of Icon Plc NASDAQ: ICLR. In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Icon stock on February 12th. The trade occurred in the Representative's "MERRILL LYNCH INVESTMENT ACCOUNT #025" account.

Representative Julia Letlow also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of HF Sinclair NYSE: DINO on 2/20/2026.
• Sold $1,001 - $15,000 in shares of BXP NYSE: BXP on 2/20/2026.
• Purchased $1,001 - $15,000 in shares of Travelers Companies NYSE: TRV on 2/20/2026.
• Sold $1,001 - $15,000 in shares of Expand Energy NASDAQ: EXE on 2/17/2026.
• Sold $1,001 - $15,000 in shares of Public Service Enterprise Group NYSE: PEG on 2/17/2026.
• Purchased $1,001 - $15,000 in shares of Vistra NYSE: VST on 2/17/2026.
• Purchased $1,001 - $15,000 in shares of Regeneron Pharmaceuticals NASDAQ: REGN on 2/12/2026.
• Purchased $1,001 - $15,000 in shares of Extra Space Storage NYSE: EXR on 2/12/2026.
• Sold $1,001 - $15,000 in shares of AT&T NYSE: T on 2/12/2026.
• Sold $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 2/12/2026.

Icon Stock Up 0.7%

ICLR opened at $100.35 on Tuesday. Icon Plc has a 12 month low of $66.57 and a 12 month high of $211.00. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31. The business's 50-day moving average price is $132.92 and its 200-day moving average price is $162.07. The company has a market cap of $8.10 billion, a P/E ratio of 13.58, a P/E/G ratio of 2.55 and a beta of 1.35.

Hedge Funds Weigh In On Icon

Several hedge funds have recently made changes to their positions in the business. Private Trust Co. NA boosted its stake in Icon by 200.0% during the third quarter. Private Trust Co. NA now owns 141 shares of the medical research company's stock worth $25,000 after acquiring an additional 94 shares in the last quarter. Toth Financial Advisory Corp bought a new position in shares of Icon during the fourth quarter valued at approximately $27,000. EFG International AG purchased a new position in shares of Icon during the fourth quarter valued at approximately $27,000. Ameriflex Group Inc. bought a new stake in shares of Icon in the 3rd quarter worth approximately $33,000. Finally, Abound Financial LLC purchased a new stake in shares of Icon in the 4th quarter worth approximately $54,000. 95.61% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ICLR has been the subject of several recent research reports. BMO Capital Markets reiterated a "market perform" rating and issued a $100.00 price objective on shares of Icon in a research report on Thursday, February 12th. Bank of America reaffirmed an "underperform" rating and issued a $75.00 target price on shares of Icon in a research note on Thursday, February 12th. Robert W. Baird set a $119.00 price target on shares of Icon in a report on Friday, February 13th. Zacks Research lowered shares of Icon from a "hold" rating to a "strong sell" rating in a report on Wednesday, February 25th. Finally, Citigroup decreased their price objective on shares of Icon from $200.00 to $120.00 and set a "neutral" rating on the stock in a research report on Wednesday, March 11th. Six research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $146.80.

About Representative Letlow

Julia Letlow (Republican Party) is a member of the U.S. House, representing Louisiana's 5th Congressional District. She assumed office on April 14, 2021. Her current term ends on January 3, 2027. Letlow (Republican Party) is running for re-election to the U.S. House to represent Louisiana's 5th Congressional District. She declared candidacy for the primary scheduled on November 3, 2026. Julia Letlow earned a doctorate. Letlow's career experience includes working as a senior administrator with the University of Louisiana at Monroe.

Icon Company Profile

Icon plc NASDAQ: ICLR is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon's service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.